Nutritional guidance for GLP-1 weight loss medication users

The rise of GLP-1 receptor agonists, such as Ozempic, Wegovy, Mounjaro, and Zepbound, has transformed the global approach to obesity by targeting brain satiety centers and slowing digestion. While effective at reducing appetite and portion sizes, these medications present nutritional risks due to the drastic reduction in calorie intake.

Experts warn that insufficient nutrient density can lead to side effects including hair loss, extreme exhaustion, loss of skin elasticity, and digestive issues. To mitigate these risks, a strategic dietary approach is recommended, focusing on nutrient-dense foods.

A primary concern is the loss of lean muscle mass during rapid weight loss. Maintaining muscle is essential for preserving basal metabolism and preventing the ‘yo-yo effect’ after therapy ends. Specialists advise prioritizing high-quality, easily digestible proteins, such as poultry and various types of fish, to support muscle preservation.